WHO calls for trials of fractional dosing of monkeypox vaccineOne day after the United States said it would allow intradermal, fractional dosing of Bavarian Nordic's monkeypox vaccine, Jynneos, the World Health Organization (WHO) called for more trials on the practice.The European Medicines Agency (EMA) told Reuters it will discuss the intradermal approach.
For now, some European countries, including the United Kingdom, are extending the interval between the two doses of vaccine to allow more people to get their initial shot.The WHO said trials will give countries critical information about how intradermal administration and fractional dosing could work for this outbreak.Yesterday, the Centers for Disease Control and Prevention reported 558 more monkeypox cases, raising the total to 9,492.Globally, the outbreak stands at almost 32,000 cases.Finally today, Gilead, a major maker of HIV drugs, is partnering with LGBTQ+ organizations to contribute up to $5 million in grants to help with monkeypox education efforts.
In part, the money will go towards education programs, with the goal of correcting misinformation."As we saw with HIV, COVID-19, and now MPV [monkeypox virus], disinformation continues to challenge the LGBTQ+ community," said Sarah Kate Ellis, president and CEO of GLAAD, in a press release. "This new collaboration will enable creating and distributing content and resources to help our community know the facts and to understand prevention and treatment for MPV."Aug 10 Reuters storyAug 10 CDC updateAug 10 Global Health documentAug 9 Gilead press releaseUK to offer polio vaccine for London children amid more wastewater detectionsFollowing a recommendation from its vaccine advisory group, the United Kingdom Health